Literature DB >> 4322461

Immunoreactive corticotrophin levels in adrenocortical insufficiency.

G M Besser, D R Cullen, W J Irvine, J G Ratcliffe, J Landon.   

Abstract

Plasma concentrations of immunoreactive corticotrophin (ACTH) have been determined in 14 patients with untreated Addison's disease and in 42 patients with secondary adrenocortical insufficiency. Basal morning plasma ACTH levels were markedly raised in those with Addison's disease but were either in the normal range or undetectable in the group with secondary adrenocortical insufficiency. In the group with Addison's disease circulating ACTH values showed a definite nyctohemeral rhythm, a pronounced rise in response to insulin-induced hypoglycaemia, and an immediate fall following the intravenous injection of corticosteroids, with a half-life of between 13.5 and 44.2 minutes. When assays were performed with antisera directed against the portion of the ACTH molecule responsible for corticosteroidogenesis (the N-terminal portion) the apparent ACTH concentrations were lower than with antisera directed against the non-steroidogenic (C-terminal) portion of the molecule. This emphasizes that different antisera may give different apparent hormone concentrations, and that the ranges of values obtained in normal and abnormal states must be established for each antiserum.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4322461      PMCID: PMC1795012          DOI: 10.1136/bmj.1.5745.374

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  PERSISTENCE OF DIURNAL RHYTHMICITY IN PLASMA ACTH CONCENTRATIONS IN CORTISOL-DEFICIENT PATIENTS.

Authors:  A L GRABER; J R GIVENS; W E NICHOLSON; D P ISLAND; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1965-06       Impact factor: 5.958

2.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Endocrine function in patients with untreated chromophobe adenomas.

Authors:  E A Nieman; J Landon; V Wynn
Journal:  Q J Med       Date:  1967-07

4.  A clinical and immunological study of adrenocortical insufficiency (Addison's disease).

Authors:  W J Irvine; A G Stewart; L Scarth
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

5.  Effect of hypothalamic deafferentation on the control of luteinizing hormone secretion.

Authors:  S Taleisnik; M E Velasco; J J Astrada
Journal:  J Endocrinol       Date:  1970-01       Impact factor: 4.286

6.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa.

Authors:  J Landon; F C Greenwood; T C Stamp; V Wynn
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

7.  Proposed system of terminology for preparations of adrenocorticotropic hormone.

Authors:  C H LI
Journal:  Science       Date:  1959-04-10       Impact factor: 47.728

  7 in total
  9 in total

1.  Addisonian crisis presenting with a normal short tetracosactrin stimulation test.

Authors:  G P Butcher; M Zambon; S Moss; J R Walters
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  Plasma corticotrophin levels in addison-schilder's disease.

Authors:  L H Rees; D B Grant; J Wilson
Journal:  Br Med J       Date:  1975-07-26

3.  Endocrinopathy in thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

4.  Diagnosis of adrenal insufficiency.

Authors:  R N Clayton
Journal:  BMJ       Date:  1989-02-04

5.  Physiology of adrenal cortical function.

Authors:  G M Besser
Journal:  Br Med J       Date:  1972-01-29

6.  Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

Authors:  S M Atherden; N D Barnes; D B Grant
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

Review 7.  Cytochemistry in the bioassay of hormones.

Authors:  J Chayen; L Bitensky
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

8.  Familial glucocorticoid deficiency. Studies of diagnosis and pathogenesis.

Authors:  D Thistlethwaite; J A Darling; R Fraser; P A Mason; L H Rees; R A Harkness
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

9.  Hypothalamic-pituitary-adrenal function in patients treated with long-term depot tetracosactrin.

Authors:  W J Irvine; D R Cullen; S A Khan; J G Ratcliffe
Journal:  Br Med J       Date:  1971-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.